Labcorp (LH) announced the clinical availability of Labcorp Plasma Complete, a circulating tumor DNA-based comprehensive genomic profiling ...
Labcorp® Plasma CompleteTM offers oncologists a highly sensitive and specific genomic profiling solution from a simple blood draw BURLINGTON, N.C., Feb. 24, 2025 ...
Labcorp Holdings Inc. leverages strategic moves like the Fortrea spin-off and Invitae acquisition to drive growth. Read more ...
11 个月
Zacks.com on MSNLabcorp (LH) Boost Diagnostics Suite With New Biomarker TestWith more than 67,000 workers, Labcorp provides services to customers in more than 100 nations and completed more than 600 million patient tests worldwide last year. A major step forward in ...
Monday – Friday: 7 a.m. to 4 p.m. The center’s Tier 1 lab is run by LabCorp. Fax orders for lab work to LabCorp at 765-496-6656. For after hours and weekend care, you may contact the Anthem NurseLine ...
10 个月
GlobalData on MSNLabcorp launches blood test for neurodegenerative diseases detectionGlobal life sciences company Labcorp has announced the first commercially available glial fibrillary acidic protein (GFAP) ...
The new facility will allow Labcorp to process more than 110,000 patient specimens daily. RARITAN BOROUGH - Labcorp, on First Avenue, has celebrated the opening of 110,000 square feet of ...
Labcorp has struck an agreement to manage the daily operations of Vineland, N.J.-based Inspira Health's hospital laboratories in Vineland, Elmer, and Mullica Hill. The company will provide ...
“By investing in advanced technology and infrastructure, we’re positioning Labcorp to scale operations to best serve the company’s growing demand and enhancing patient care by supporting ...
Labcorp Holdings Inc. LH, or Labcorp, is slated to report its fourth-quarter 2024 results on Feb. 6 before the opening bell. The renowned laboratory service provider reported adjusted earnings of ...
Schechter highlighted a strong pipeline of hospital and laboratory acquisitions, emphasizing their alignment with Labcorp’s financial criteria. Lisa Gill, JP Morgan, questioned Diagnostics growth.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果